Versant Venture Management, LLC
Source: SEC Form 13F · as of Mar 2026Versant Venture Management, LLC holds 3 biotech & pharma companies tracked by BioSniper, totaling $80.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
3
Total value held
$80.8M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Monte Rosa Therapeutics, Inc. (GLUE)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GLUEMonte Rosa Therapeutics, Inc. | 3,180,780 | $52.3M |
| JBIOJade Biosciences, Inc. | 1,525,820 | $21.4M |
| CRSPCRISPR Therapeutics AG | 148,831 | $7.1M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.